hyperlocomotion phenotype
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| amphetamine | risk_factor_for | hyperlocomotion | — | 1 |
| BIS | protective_against | hyperlocomotion | — | 1 |
| cocaine | risk_factor_for | hyperlocomotion | — | 1 |
| MAPK3 | regulates | hyperlocomotion | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- A comparison of word embeddings for the biomedical natural language processing. (2018)
- Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. (2018)
- Nuclear organization and 3D chromatin architecture in cognition and neuropsychiatric disorders. (2016)
- Early maternal alcohol consumption alters hippocampal DNA methylation, gene expression and volume in a mouse model. (2015)
- The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review. (2014)
- Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- Protein kinases and addiction. (2008)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| hyperlocomotion | phenotype | 7 | 14 |
| hyperlocomotor activity | phenotype | 1 | 1 |